They raised $5.8 million in December 2019 through options (81% taken up by shareholders with underwriter taking the rest).
In the quarterly released last month they were sitting on more than $8 million with expected costs for next quarter $1.48 million (which included increased R&D costs). That means they have plenty to keep operating for more than a year.
